Neuroenhancement drugs are a hot topic these days, especially among students. The New Yorker looked at the issue in April, reporting that "white male undergraduates at highly competitive schools—especially in the Northeast—are the most frequent collegiate users of neuroenhancers." Now Michael A. Williams, MD, FAAN, the medical director of the Sandra and Malcolm Berman Brain & Spine Institut e has co-authored a report titled "Responding to requests from adult patients for neuroenhancements," which was published in the September 23 online issue of Neurology.
The report provides guidelines for neurologists prescribing the drugs, which were originally created to help those with attention deficit disorder or memory problems from diseases like Alzheimer's. There is limited research on the safety and efficiency of the drugs in healthy adults.
The report provides guidelines for neurologists prescribing the drugs, which were originally created to help those with attention deficit disorder or memory problems from diseases like Alzheimer's. There is limited research on the safety and efficiency of the drugs in healthy adults.
To learn more about the institute, click here.